Larvol Delta - MAGICG1-A-Study-of-Intratumoral-Administered-MTX110-in-Patients-With-Recurrent-Glioblastoma

panobinostat (MTX110) - Biodexa Pharma

http://clinicaltrials.gov/ct2/show/NCT05324501

Feb 29, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next